IN2012DN01849A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01849A
IN2012DN01849A IN1849DEN2012A IN2012DN01849A IN 2012DN01849 A IN2012DN01849 A IN 2012DN01849A IN 1849DEN2012 A IN1849DEN2012 A IN 1849DEN2012A IN 2012DN01849 A IN2012DN01849 A IN 2012DN01849A
Authority
IN
India
Prior art keywords
vwf
provides methods
present
von willebrand
willebrand factor
Prior art date
Application number
Other languages
English (en)
Inventor
Mitterer Artur
Hasslacher Meinhard
Mayer Christa
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43063204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN01849(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of IN2012DN01849A publication Critical patent/IN2012DN01849A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN1849DEN2012 2009-08-20 2010-08-20 IN2012DN01849A (en, 2012)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23557009P 2009-08-20 2009-08-20
PCT/US2010/046180 WO2011022657A1 (en) 2009-08-20 2010-08-20 Purification of vwf for increased removal of non-lipid enveloped viruses

Publications (1)

Publication Number Publication Date
IN2012DN01849A true IN2012DN01849A (en, 2012) 2015-08-21

Family

ID=43063204

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1849DEN2012 IN2012DN01849A (en, 2012) 2009-08-20 2010-08-20

Country Status (18)

Country Link
US (1) US9315560B2 (en, 2012)
EP (1) EP2467399B2 (en, 2012)
JP (1) JP5838159B2 (en, 2012)
KR (1) KR101894600B1 (en, 2012)
CN (2) CN106008697B (en, 2012)
AU (1) AU2010284116B9 (en, 2012)
BR (1) BR112012003802B1 (en, 2012)
CA (1) CA2771232A1 (en, 2012)
DK (1) DK2467399T3 (en, 2012)
ES (1) ES2562256T5 (en, 2012)
HU (1) HUE026907T2 (en, 2012)
IN (1) IN2012DN01849A (en, 2012)
MX (1) MX2012002129A (en, 2012)
NZ (1) NZ598249A (en, 2012)
PL (1) PL2467399T3 (en, 2012)
PT (1) PT2467399E (en, 2012)
SG (2) SG10201408106WA (en, 2012)
WO (1) WO2011022657A1 (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
PL2349314T3 (pl) * 2008-10-21 2013-07-31 Baxalta Inc Formulacje liofilizowanego rekombinowanego VWF
MY173835A (en) * 2012-06-21 2020-02-24 Baxter Int Virus filtration of cell culture media
JP6320429B2 (ja) * 2013-02-22 2018-05-09 エイジェンシー・フォー・サイエンス,テクノロジー・アンド・リサーチ 負帯電粒子を用いるウイルス調製物のクロマトグラフィー精製
ES2895798T3 (es) * 2014-06-06 2022-02-22 Octapharma Ag Preparación que comprende péptidos del factor VIII y del factor Von Willebrand
WO2015188224A1 (en) 2014-06-13 2015-12-17 Csl Limited Improved production of recombinant von willebrand factor in a bioreactor
EP3672644A1 (en) 2017-08-23 2020-07-01 CSL Behring GmbH Method for virus filtration of von willebrand factor
US10934340B2 (en) 2018-03-21 2021-03-02 Baxalta Incorporated Separation of VWF and VWF propeptide by chromatographic methods
EP4490042A1 (en) 2022-03-08 2025-01-15 Equashield Medical Ltd. Fluid transfer station in a robotic pharmaceutical preparation system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
WO1986006096A1 (en) 1985-04-11 1986-10-23 The Children's Medical Center Corporation Von willebrand factor
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
AT405403B (de) * 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406373B (de) * 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
US6531577B1 (en) 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
ATE321066T1 (de) * 1998-05-06 2006-04-15 Genentech Inc Anti-her2 antikörperzusammensetzung
WO2006071801A2 (en) 2004-12-27 2006-07-06 Baxter International Inc Polymer-von willebrand factor-conjugates

Also Published As

Publication number Publication date
EP2467399B2 (en) 2023-02-01
AU2010284116A1 (en) 2012-03-08
US9315560B2 (en) 2016-04-19
ES2562256T5 (es) 2023-07-20
EP2467399B1 (en) 2015-11-11
BR112012003802A2 (pt) 2016-11-22
WO2011022657A1 (en) 2011-02-24
BR112012003802B1 (pt) 2022-10-25
KR20120065342A (ko) 2012-06-20
JP5838159B2 (ja) 2015-12-24
CN106008697B (zh) 2020-08-04
SG10201408106WA (en) 2015-01-29
CA2771232A1 (en) 2011-02-24
PL2467399T3 (pl) 2016-05-31
DK2467399T3 (en) 2017-01-23
MX2012002129A (es) 2012-06-08
CN106008697A (zh) 2016-10-12
PT2467399E (pt) 2016-03-18
SG178478A1 (en) 2012-04-27
AU2010284116B2 (en) 2015-02-12
US20110092681A1 (en) 2011-04-21
CN102482341A (zh) 2012-05-30
EP2467399A1 (en) 2012-06-27
NZ598249A (en) 2014-04-30
HUE026907T2 (en) 2016-07-28
ES2562256T3 (es) 2016-03-03
JP2013502434A (ja) 2013-01-24
AU2010284116B9 (en) 2015-03-26
KR101894600B1 (ko) 2018-09-03

Similar Documents

Publication Publication Date Title
IN2012DN01849A (en, 2012)
IN2014DN08481A (en, 2012)
GB0917002D0 (en) Improved shigella blebs
MA35660B1 (fr) Inhibiteurs de la protéine pak pour le traitement du syndrome de l'x fragile
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
EA201390145A1 (ru) Конъюгаты, частицы, композиции и связанные с ними способы
SG10201804385YA (en) Stimulus responsive polymers for the purification of biomolecules
MY161252A (en) Viral inactivation using improved solvent-detergent method
EA201391175A1 (ru) Гетеродимерные иммуноглобулины
UA104459C2 (uk) Антитіла проти fgfr3 і способи їх застосування
EA202193044A2 (ru) Способы лечения таупатии
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
UA105785C2 (uk) Спосіб очищення ліпопептидів
EP2588083A4 (en) BIOMATRIXGERÜSTE
UA110470C2 (ru) Антидот антикоагулянта
EP2569330A4 (en) CHLOROTOXIN VARIANTS AND CONJUGATES AND METHOD OF USE THEREOF
EA201590887A1 (ru) Композиция
JO3755B1 (ar) تركيبات تستوستيرون
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
UA107476C2 (uk) Фармацевтична субстанція на основі мітохондріально адресованих антиоксидантів
EA201490688A1 (ru) 2-тиопиримидиноны
UY34329A (es) Compuestos de triazolopiridina
MX363617B (es) Metodo para la purificacion de compuestos de difosfitos organicos.
CO6821958A2 (es) Tetrahidroquinolinas condensadas con cicloalquilo como moduladores de receptores de crth2
IN2014DN08412A (en, 2012)